Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib with HAART in AIDS-associated Kaposi's Sarcoma
NCT01752569Phase 2Terminated
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selumetinib in Kaposi sarcoma (KS), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jun 2012; status: terminated.
02
Drugs
selumetinib
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT01752569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01752569.